A medical device company changing the cancer treatment balance in survivorship and quality of life: improving both
Sensius has raised $7.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
Sensius's investors include European Innovation Council, UNIIQ, EISMEA.
Sensius is headquartered in Rotterdam, The Netherlands.
A medical device company changing the cancer treatment balance in survivorship and quality of life: improving both
Sensius is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sensius — Funding & Investors." VCBacked, February 15, 2023, https://www.vcbacked.co/company/sensius. Accessed August 14, 2026.
VCBacked. (2023). Sensius — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sensius
{{cite web |title=Sensius — Funding & Investors |url=https://www.vcbacked.co/company/sensius |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated